Global leading doctors from Oxford and Vanderbilt, published independent clinical validation of Optellum Lung Cancer Prediction AI in the "Blue Journal", the leading publication in the field - illustrating potential…
Optellum has strengthened leadership team to support the commercialisation and clinical validation of its first product, and the development of product pipeline in the treatment of lung cancer and other…
Optellum Chairman & co-founder, Prof. Sir Michael Brady FRS (center), is named the founding Board of Trustees member, and the interim President of the world's first AI University. Prof Sir…
Optellum Founder and Chief Science & Technology Officer will share the lessons learned by Optellum in enabling early lung cancer diagnosis & treatment at the AI@Oxford congress. University of Oxford…
IASLC World Conference on Lung Cancer, the world's premier event for physicians and scientists advancing the fight against world's deadliest cancer, is taking place from September 7th till September 10…
The Optellum team is excited to be selected for the 2019 Digital Health Accelerator Cohort at TMCx, to be spend 4 months building our business with industry and clinical experts…
Optellum team and advisors took the lead role in preparing the winning bid, with Optellum Chairman, Prof Sir Michael Brady FRS named the Executive Chairman of the NCIMI consortium led…
This week Optellum has been highlighted in three presentations at the IASLC World Conference on Lung Cancer in Toronto, Canada. On Tuesday, Dr. Peter van Ooijen, from University Medical Centre…
Optellum welcomes an internationally renowned physician and scientist in early lung cancer diagnosis and treatment, Dr. Sam Janes MD, to join its Medical Advisory Board. Prof. Janes works as a respiratory…
Join us at the American Thoracic Society 2018 Congress in San Diego, North America's premier congress for pulmonary medicine, from May 20 till May 23. Meet us at Booth No…
Delighted to welcome Dr. Christine Berg, the co-Principal Investigator of the US National Lung Screening Trial (NLST), the biggest ever randomized clinical study, to learn more about Optellum and our work…
Optellum Scientific Advisory Board welcomes Leo Grady, an internationally recognized expert in healthcare machine learning and building medical imaging Software-as-a-Service (SaaS) products. Leo Grady, Ph.D. (Senior Vice President of Engineering,…